From the MeOH extract of the root bark of Artocarpus lakoocha, a new compound 5,7,2′,4′-tetrahydroxy-6-geranyl-3-prenyl-flavone (1) was isolated, along with three known flavonoids (+)-afzelechin-3-O--L-rhamnopyranoside (2), (+)-catechin (3) and cudraflavone C (4). Evaluation of these isolates for inhibitory effects against Herpes simplex virus (HSV) types 1 and 2 was carried out using the inactivation method. Compounds 1 and 4 showed moderate and weak activity against both types of HSV, respectively, whereas 2 and 3 were devoid of activity.
Artocarpus lakoocha Roxb. (Moraceae), locally known in Thai as "Ma-Hadd", is a medicinal plant widely distributed in South and Southeast Asia [1] . In Thailand, a dried aqueous extract obtained from the heartwood of the plant has been traditionally used as an anthelmintic drug, and oxyresveratrol, the major constituent, has been shown to have anti-Herpes simplex virus (HSV) activity [2, 3] . Our previous study on the EtOAc extract of the root bark of this plant revealed the presence of three 2-arylbenzofurans, which, however, possessed no anti-HSV activity [4] . In this current examination, we focused on the MeOH extract, which showed 80% inhibition at a concentration of 100 g/mL against both types of HSV-1 and HSV-2. A chemical investigation of this extract led to the isolation of a new flavone 5,7,2′,4′-tetrahydroxy-6-geranyl-3-prenyl-flavone (1), as well as three known flavonoids, (+)-afzelechin-3-O--L-rhamnopyranoside (2) [5] , (+)-catechin (3) [6] and cudaflavone C (4) [7] (Figure 1 ). Each of these isolates was then evaluated for anti-HSV activity. to C-3 ( of ring C, as suggested from the HMBC correlations from H 2 -9 to C-2 ( 161.9), C-4 (and C-11 (. The HMBC correlations of H 2 -14 with C-6 (111.7) and C-5 (160.0) placed the geranyl group at C-6 of ring A. Based on the above spectral evidence, 1 was characterized as 5,7,2′,4′-tetrahydroxy-6-geranyl-3-prenyl-flavone. It should be noted that 1 is a structural isomer of rubraflavone C, a prenylated flavonoid reported from Morus rubra and Artocarpus rigida [9] . The two compounds share the same substitution pattern, but they have the prenyl and geranyl groups located at reverse positions.
Evaluation of anti-HSV activity of the isolates (1-4) was performed by the plaque reduction assay (inactivation) [3] . 5,7,2′,4′-Tetrahydroxy-6-geranyl-3-prenyl-flavone (1) showed moderate activity against both HSV-1 and HSV-2 with IC 50 values of 25.5±4.2 and 25.5±5.7 M, respectively, as compared with the positive control acyclovir (IC 50 0.25 M and 2.24 M for HSV-1 and HSV-2, respectively). Cudraflavone C (4) exhibited marginal activity, with an IC 50 value of 237±5.6 M against HSV-1 and 237±7.5 M against HSV-2, whereas (+)-afzelechin-3-O--Lrhamnopyranoside (2) and (+)-catechin (3) were devoid of such activity at a concentration of 100 g/mL. 
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Experimental
General procedure: UV spectra were obtained on a Milton Roy Spectronic 3000 Array spectrophotometer, and IR spectra on a Perkin-Elmer FT-IR 1760X spectrophotometer. ESI-TOF-MS were recorded on a Micromass LCT mass spectrometer. NMR spectra were recorded either on Bruker Avance DPX-300 FT-NMR or Varian Unity INOVA-500 NMR spectrometers. Vacuum-liquid column chromatography (VLC) and column chromatography (CC) were performed on silica gel 60 (70-320 mesh or 30-400 mesh, Merck, Diaion HP-220SS (Supelco) and Sephadex LH-20 (25-100 m, Pharmacia Fine Chemical). 
Extraction and isolation:
Air dried and powdered root bark of A. lakoocha (2.4 kg) was extracted with MeOH (3  20 L) at room temperature to give a MeOH extract (369 g) after removal of the solvent. A portion of this extract (10 g) was passed through Diaion HP-220SS (H 2 O-MeOH) to give 6 fractions. Fraction 1 (2 g) was subjected to CC (silica gel, CH 2 Cl 2 -MeOH) and then size exclusive CC (Sephadex LH-20, MeOH) to give 2 (8 mg) and 3 (15 mg). Fraction 6 (500 mg) was separated by CC (silica gel, MeOH-CH 2 Cl 2 , gradient) and then by Sephadex LH-20 (MeOH-CH 2 Cl 2 , 7:3) to give 1 (54 mg) and 4 (5 mg).
Assay of anti-HSV activity: Antiviral activity against HSV-1 (Strain KOS) and HSV-2 (Strain 186) was determined using the plaque reduction method, as previously described. Briefly, virus (30 PFU/25 L) was mixed with 25 L of complete medium containing various concentrations of each test compound and then incubated at 37ºC for 1h. After incubation, the mixtures were added to Vero cells (6 x 10 5 cells/well) in 96-well microtiter plates and incubated at 37ºC for 2 h. The overlay medium containing the various concentrations of each test compound was added to the Vero cells and incubated at 37ºC in a humidified CO 2 incubator for 48 h. Then, virus growth inhibition was evaluated by counting the virus plaques forming on Vero cells compared with the controls. The cells also were stained with 1% crystal violet in 10% formalin for 1 h. The percent plaque inhibition was determined. Acyclovir was used as a positive control. 5,7,2′,4′-Tetrahydroxy-6-geranyl-3-prenyl-flavone (1 
